SI-BONE Inc Dossier
Outlook & Key Dates
Estimates, guidance, catalysts, and upcoming events
Analyst Estimates Learn more →
5-Yr Fwd EPS Growth
26.2%projected annual EPS growth
Analyst Coverage
8analysts covering
FY Revenue (est.)
$231.6Mnext fiscal year
FY EPS (est.)
-$0.43next fiscal year
Reporting Calendar
| Event | Expected Date |
|---|---|
| Q3 2026 Earnings Release | 9 Nov 2026 |
Monitoring Framework
Key Performance Indicators
Worldwide Revenue Quarterly52.6MTarget: 230000000 to 233000000
Active U.S. Physicians Quarterly1.7K
Annual Revenue per Territory Manager Quarterly2.2M
Gross Margin Quarterly79.8%
Watch Items
- Smith & Nephew Trauma Distribution PartnershipTrigger: Pace of trauma distributor onboarding and commercial executionAction: Monitor quarterly trauma-related revenue contributions and distributor activation metrics.
- CMS FY2027 IPPS Proposed Rule FinalizationTrigger: Creation of a new MS-DRG family with higher payment for complex spinal fusion procedures incorporating iFuse Bedrock GraniteAction: Track CMS final rule publication in late summer/fall and assess hospital adoption rates.
- Breakthrough Device CommercializationTrigger: Filing for a new Breakthrough Device in Q3 2026 and subsequent commercial launchAction: Verify regulatory submission timeline and initial commercial rollout milestones.
Research as of 19 Jun 2026